flumazenil has been researched along with Antiphospholipid Syndrome in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Manzano-Gamero, V | 1 |
Pardo-Cabello, AJ | 1 |
Vargas-Hitos, JA | 1 |
Zamora-Pasadas, M | 1 |
Navarrete-Navarrete, N | 1 |
Sabio, JM | 1 |
Jáimez-Gámiz, L | 1 |
Ríos-Fernandez, R | 1 |
Ortego-Centeno, N | 1 |
Ayala-Gutierrez, MM | 1 |
de Ramón, E | 1 |
Colodro-Ruíz, A | 1 |
Micó-Giner, L | 1 |
Castillo-Palma, MJ | 1 |
Robles-Marhuenda, Á | 1 |
Luna-Del Castillo, JD | 1 |
Jiménez-Alonso, J | 1 |
1 other study available for flumazenil and Antiphospholipid Syndrome
Article | Year |
---|---|
Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; B | 2018 |